Spero Therapeutics

SPRO

Börsenwert 64,6 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Atlas Venture Associates IX Boston, Massachusetts	13,2 Mio. $	–	–	–
2	ACM 2 Aquilo Capital Management San Francisco, California	11,1 Mio. $	–	–	–
3	3 Alphabet Inc Mountain View, California	10,7 Mio. $	–	–	–
4	4 Novo Holdings A/S Hellerup, Denmark	8,95 Mio. $	+5,02 Mio. $	+465.116	+100 %
5	5 BVF Inc San Francisco, California	8,13 Mio. $	-1,02 Mio. $	-94.299	-10 %
6	6 BlackRock New York	7,26 Mio. $	+822.984 $	+76.316	+11 %
7	7 Rock Springs Capital Management Baltimore, Maryland	5,05 Mio. $	–	–	–
8	AG 8 Artal Group Luxembourg	4,81 Mio. $	-431.356 $	-40.000	-7 %
9	9 Vanguard Group Malvern, Pennsylvania	4,77 Mio. $	-3.084 $	-286	-0,1 %
10	AIC 10 AWM Investment Company New York	4,56 Mio. $	-1,34 Mio. $	-123.971	-21 %
11	11 VHCP Management II New York	4,56 Mio. $	–	–	–
12	12 Renaissance Technologies New York	3,25 Mio. $	+920.945 $	+85.400	+34 %
13	13 State Street Boston, Massachusetts	2,01 Mio. $	+122.559 $	+11.365	+6 %
14	14 Dimensional Fund Advisors Austin, Texas	1,5 Mio. $	+350.207 $	+32.475	+26 %
15	15 Granahan Investment Management Waltham, Massachusetts	1,43 Mio. $	+14.278 $	+1.324	+0,9 %
16	16 Northern Trust Chicago, Illinois	1,31 Mio. $	+171.604 $	+15.913	+13 %
17	17 JP Morgan Chase New York	1,28 Mio. $	-360.700 $	-33.448	-20 %
18	18 OrbiMed New York	1,27 Mio. $	-97.659 $	-9.056	-6 %
19	19 Geode Capital Management Boston, Massachusetts	1,15 Mio. $	+28.793 $	+2.670	+2 %
20	20 Fidelity Investments Boston, Massachusetts	951.000 $	-772.515 $	-71.636	-42 %
21	21 Bridgeway Capital Management Houston, Texas	679.000 $	+172.542 $	+16.000	+29 %
22	22 Oxford Asset Management Oxford, United Kingdom	566.000 $	-171.895 $	-15.940	-21 %
23	23 Jacobs Levy Equity Management Florham Park, New Jersey	441.000 $	+385.934 $	+35.788	+356 %
24	24 Panagora Asset Management Boston, Massachusetts	394.000 $	-104.744 $	-9.713	-19 %
25	25 Nuveen Charlotte, North Carolina	369.000 $	-59.258 $	-5.495	-13 %

Spero Therapeutics SPRO Börsenwert 64,6 Mio. $

Spero Therapeutics

SPRO

Börsenwert 64,6 Mio. $